31 Mar 2017 13:45
BioPharma Credit PLC (the "Company")
Total Voting Rights
31 March 2017
In conformity with the Disclosure Guidance and Transparency Rules, the Company notifies that following the Initial and Subsequent Admissions on 27 March 2017 and 30 March 2017 respectively, the issued share capital and voting rights of the Company are as follows:
Class of share | Total number of shares in circulation | Number of voting rights attached to each share | Total number of voting rights of shares in circulation | Number of shares held in treasury (carrying no voting rights attached until issued) | Total number of shares in issue |
Ordinary $1.00 shares | 761,877,360 | 1 | 761,877,360 | 0 | 761,877,360 |
The above total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in BioPharma Credit PLC under the FCA's Disclosure Guidance and Transparency Rules.
Terms not otherwise defined herein have the meaning given to them in the Prospectus of the Company dated 1 March 2017.
FOR FURTHER INFORMATION:
Pharmakon Advisors, LP via CNC Communications Tel: +44 (0)20 3219 8800
Tom Buchanan
Katherine Fennell
J.P. Morgan Cazenove Tel: +44 (0)20 7742 4000
Nicholas Hall
William Simmonds
Oliver Kenyon
Goldman Sachs International Tel: +44 (0)20 7774 1000
Richard Cormack
Daniel Martin
Shomick Bhattacharya